Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apellis Pharmaceuticals Inc COM | 2,880,880 | 3,006,980 | +126,100 | $110.51M | $86.72M | 13.88% | -$23.79M |
| Verona Pharma PlcADS | 1,895,200 | 1,835,200 | -60,000 | $27.40M | $52.80M | 8.45% | +$25.39M |
| Structure Therapeutics IncADS | 1,140,060 | 1,198,000 | +57,940 | $44.77M | $52.58M | 8.42% | +$7.81M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,746,667 | 1,746,667 | 0 | $45.20M | $47.82M | 7.66% | +$2.62M |
| ArriVent BioPharma, Inc.(AVBP) | 1,803,304 | 1,976,387 | +173,083 | $33.45M | $46.45M | 7.44% | +$12.99M |
| Centessa Pharmaceuticals PlcADS | 2,345,075 | 2,012,052 | -333,023 | $21.18M | $32.17M | 5.15% | +$11.00M |
| Insmed Incorporated(INSM) | 650,216 | 436,820 | -213,396 | $43.56M | $31.89M | 5.10% | -$11.68M |
| Nuvation Bio Inc.CL A(NUVB) | 431,600 | 12,171,513 | +11,739,913 | $1.26M | $27.87M | 4.46% | +$26.61M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 488,000 | 1,115,000 | +627,000 | $22.08M | $23.00M | 3.68% | +$920.5K |
| Ocular Therapeutix, Inc.(OCUL) | 2,425,000 | 2,425,000 | 0 | $16.59M | $21.10M | 3.38% | +$4.51M |
| Viridian Therapeutics, Inc.(VRDN) | 620,000 | 870,000 | +250,000 | $8.07M | $19.79M | 3.17% | +$11.73M |
| Perspective Therapeutics, Inc.(CATX) | 1,580,249 | 1,422,224 | -158,025 | $15.76M | $18.99M | 3.04% | +$3.23M |
| Mind Medicine Mindmed Inc | 2,153,000 | 3,018,000 | +865,000 | $15.52M | $17.17M | 2.75% | +$1.65M |
| Cogent Biosciences, Inc.(COGT) | 0 | 1,305,000 | +1,305,000 | $0 | $14.09M | 2.26% | +$14.09M |
| BridgeBio Pharma, Inc.(BBIO) | 690,000 | 552,000 | -138,000 | $17.48M | $14.05M | 2.25% | -$3.42M |
| Pharvaris N V COM | 0 | 620,470 | +620,470 | $0 | $11.49M | 1.84% | +$11.49M |
| Dyne Therapeutics, Inc.(DYN) | 1,180,798 | 262,726 | -918,072 | $41.67M | $9.44M | 1.51% | -$32.23M |
| Taysha Gene Therapies, Inc.(TSHA) | 4,572,222 | 4,572,222 | 0 | $10.24M | $9.19M | 1.47% | -$1.05M |
| Gossamer Bio, Inc.(GOSS) | 9,187,883 | 9,187,883 | 0 | $8.28M | $9.06M | 1.45% | +$785.6K |
| Allovir Inc | 9,800,000 | 11,202,000 | +1,402,000 | $7.09M | $9.06M | 1.45% | +$1.97M |
| EyePoint, Inc.(EYPT) | 1,093,503 | 1,093,503 | 0 | $9.51M | $8.74M | 1.40% | -$776.4K |
| Praxis Precision Medicines, Inc.(PRAX) | 260,000 | 130,000 | -130,000 | $10.75M | $7.48M | 1.20% | -$3.27M |
| Mineralys Therapeutics, Inc.(MLYS) | 600,000 | 600,000 | 0 | $7.02M | $7.27M | 1.16% | +$246.0K |
| Regulus Therapeutics Inc | 4,263,701 | 4,263,701 | 0 | $7.61M | $6.69M | 1.07% | -$916.7K |
| Ventyx Biosciences Inc | 2,391,114 | 2,391,114 | 0 | $5.52M | $5.21M | 0.83% | -$310.8K |
| Tenaya Therapeutics, Inc.(TNYA) | 2,576,200 | 2,576,200 | 0 | $7.99M | $4.97M | 0.80% | -$3.01M |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 489,596 | +489,596 | $0 | $4.35M | 0.70% | +$4.35M |
| Reneo Pharmaceuticals Inc | 2,250,000 | 2,250,000 | 0 | $3.40M | $3.83M | 0.61% | +$427.5K |
| Unicycive Therapeutics Inc | 0 | 8,559,000 | +8,559,000 | $0 | $3.49M | 0.56% | +$3.49M |
| PepGen Inc.(PEPG) | 376,117 | 376,117 | 0 | $6.00M | $3.22M | 0.51% | -$2.79M |
| Helix Acquisition Corp IiCL A | 250,000 | 250,000 | 0 | $2.56M | $2.61M | 0.42% | +$57.5K |
| Black Diamond Therapeutics I | 0 | 594,000 | +594,000 | $0 | $2.58M | 0.41% | +$2.58M |
| Annexon, Inc.(ANNX) | 400,000 | 400,000 | 0 | $1.96M | $2.37M | 0.38% | +$408.0K |
| Mersana Therapeutics Inc | 992,000 | 992,000 | 0 | $1.99M | $1.87M | 0.30% | -$119.0K |
| Century Therapeutics, Inc.(IPSC) | 1,333,650 | 666,825 | -666,825 | $3.40M | $1.14M | 0.18% | -$2.26M |
| Aerovate Therapeutics Inc | 465,440 | 465,440 | 0 | $772.6K | $972.8K | 0.16% | +$200.1K |
| Nuvation Bio Inc.W EXP 07 07 202(NUVB) | 0 | 312,336 | +312,336 | $0 | $715.2K | 0.11% | +$715.2K |
| Autolus Therapeutics plcADS(AUTL) | 176,000 | 176,000 | 0 | $612.5K | $638.9K | 0.10% | +$26.4K |
| Neurogene Inc.(NGNE) | 0 | 15,000 | +15,000 | $0 | $629.4K | 0.10% | +$629.4K |
| Rapt Therapeutics Inc | 292,000 | 292,000 | 0 | $890.6K | $586.9K | 0.09% | -$303.7K |
| Nkarta, Inc.(NKTX) | 240,000 | 120,000 | -120,000 | $1.42M | $542.4K | 0.09% | -$876.0K |
| Adicet Bio Inc | 767,799 | 0 | -767,799 | $929.0K | $0 | — | -$929.0K |
| Akero Therapeutics Inc | 283,372 | 0 | -283,372 | $6.65M | $0 | — | -$6.65M |
| An2 Therapeutics Inc | 3,220,263 | 0 | -3,220,263 | $6.92M | $0 | — | -$6.92M |
| Cybin D/B/A Helus Pharma(HELP) | 18,604,650 | 0 | -18,604,650 | $5.04M | $0 | — | -$5.04M |
| Elevation Oncology Inc | 747,000 | 0 | -747,000 | $2.02M | $0 | — | -$2.02M |
| Fate Therapeutics, Inc.(FATE) | 520,800 | 0 | -520,800 | $1.71M | $0 | — | -$1.71M |
| Jasper Therapeutics, Inc.(JSPR) | 287,500 | 0 | -287,500 | $6.53M | $0 | — | -$6.53M |
| Poseida Therapeutics Inc | 736,000 | 0 | -736,000 | $2.15M | $0 | — | -$2.15M |
| Silence Therapeutics plcADS(SLN) | 176,000 | 0 | -176,000 | $3.34M | $0 | — | -$3.34M |
| Terns Pharmaceuticals Inc | 1,364,400 | 0 | -1,364,400 | $9.29M | $0 | — | -$9.29M |